Thijs Oude Munnink

10PUBLICATIONS
36CO-AUTHORS
PharmacogenomicsRegenerative medicine (incl. stem cells)Medical virologyCancer therapy (excl. chemotherapy and radiation therapy)Medical molecular engineering of nucleic acids and proteins
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Jul 13, 2026
Design characteristics of mass balance studies conducted for protein kinase inhibitors.

|Mar 10, 2026
Ribavirin for Paramyxovirus Infections in Hematopoietic Stem-Cell Transplant and Lung Transplant Recipients: Evaluation of an Optimized Dosing Regimen.

Manon C Wilpshaar, Berdien Oortgiesen, Martijn Bakker

|Jul 25, 2025
TDM-Based Tailored Dosing of Durvalumab in Lung Cancer Patients: A Comprehensive Population Pharmacokinetic-Pharmacoeconomic Evaluation.

Fenna de Vries, Eric J F Franssen, Arthur A J Smit

|Apr 27, 2025
Metamizole induces voriconazole metabolism and results in subtherapeutic voriconazole concentrations.

Simone D Baan, Daan J Touw, Marjolijn N Lub-de Hooge

|Jun 18, 2024
Model-Informed Development of a Cost-Saving Dosing Regimen for Sacituzumab Govitecan.

Dirk J A R Moes, Jeroen J M A Hendrikx, Henk-Jan Guchelaar

|May 06, 2024
Lethal Capecitabine Toxicity in Patients With Complete Dihydropyrimidine Dehydrogenase Deficiency Due to Ultra-Rare DPYD Variants.

André B P van Kuilenburg, Marjolein C H Pleunis-van Empel, Rick B Brouwer

Pageof 2

Frequent Collaborators

2 joint publications

Rob Ter Heine

2 joint publications

Michel M van den Heuvel

2 joint publications

Jeroen J M A Hendrikx

2 joint publications

Dirk Jan A R Moes